Loading clinical trials...
Loading clinical trials...
Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk
Conditions
Interventions
Placebo-Control
Low-Dose Vitamin K2 (menaquinone-7; 45-mcg/d)
+1 more
Locations
1
United States
Medical College of Georgia; Augusta University
Augusta, Georgia, United States
Start Date
October 1, 2016
Primary Completion Date
December 1, 2020
Completion Date
December 30, 2020
Last Updated
November 20, 2019
NCT01143454
NCT00001987
NCT07472881
NCT07483723
NCT07010757
NCT06223555
Lead Sponsor
Augusta University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions